📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-12 18:42
49 analysed today
FollowTelegram
49
Today
150,000
All-time analysed
42,997
Positive
6,670
Negative
91,615
Neutral
8,650
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Aimco Pesticides Approves Q1 FY27 Results; 39th AGM Set for Sept 25, 2026
Aimco Pesticides approved its unaudited financial results for the quarter ended June 30, 2026. While the full consolidated P&L was not detailed in the summary, the company's two subsidiaries reported a combined revenue of just Rs 2.01 Lakhs and a net loss of Rs 4.36 Lakhs for the quarter. This follows a challenging FY26 where the company reported a TTM net loss of Rs 12 Cr and a negative ROCE of 34%. The 39th Annual General Meeting (AGM) is scheduled for September 25, 2026, which will be critical for understanding management's turnaround strategy.
Confidence: HIGH
What changedThe company has finalized its Q1 FY27 financial review and set the dates for its annual shareholder meeting and book closure.
Why it mattersFor a micro-cap company (Rs 48 Cr market cap) currently in a loss-making phase, these quarterly updates are vital to track if the business is nearing an operational break-even point.
Subsidiary Revenue (Q1): Rs 2.01 LakhsSubsidiary Net Loss (Q1): Rs 4.36 LakhsTTM Revenue: Rs 155 CrDebt to Market Cap: 31.25%AGM Date: September 25, 2026
📅 Short termThe stock may remain under pressure or trade sideways given the historical loss-making trend and the lack of immediate positive triggers in the subsidiary performance.
📈 Long termLong-term viability depends on the company's ability to reverse its negative ROCE (-34%) and manage its debt (Rs 15 Cr) relative to its small net worth (Rs 18 Cr).
⚠ Risk flags
- Persistent net losses (TTM PAT Rs -12 Cr)
- Negative ROCE of -34.0%
- High debt-to-equity ratio (0.83) for a micro-cap
- Declining revenue trend over the last four quarters
Key Highlights
Board approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2026
Two subsidiaries reported a combined revenue of Rs 2.01 Lakhs for the quarter
Subsidiaries incurred a combined net loss after tax of Rs 4.36 Lakhs
39th Annual General Meeting scheduled for September 25, 2026, via video conferencing
Share transfer books to remain closed from September 19 to September 25, 2026
👀 What to Watch
Investors should examine the full Q1 P&L statement to see if the operating margins have improved from the -7.2% TTM OPM and if revenue has stabilized after the decline from Rs 48.32 Cr in June 2025 to Rs 30.64 Cr in March 2026.
